Publication: Antimalarial bioavailability and disposition of artesunate in acute falciparum, malaria
2
Issued Date
2000-04-01
Resource Type
ISSN
00664804
Other identifier(s)
2-s2.0-0034065696
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.44, No.4 (2000), 972-977
Suggested Citation
Paul Newton, Yupin Suputtamongkol, Paktiya Teja-Isavadharm, Sasithon Pukrittayakamee, V. Navaratnam, Imelda Bates, Nicholas White Antimalarial bioavailability and disposition of artesunate in acute falciparum, malaria. Antimicrobial Agents and Chemotherapy. Vol.44, No.4 (2000), 972-977. doi:10.1128/AAC.44.4.972-977.2000 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26261
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Antimalarial bioavailability and disposition of artesunate in acute falciparum, malaria
Abstract
The pharmacokinetic properties of oral and intravenous artesunate (2 mg/kg of body weight) were studied in 19 adult patients with acute uncomplicated Plasmodium falciparum malaria by using a randomized crossover design. A sensitive bioassay was used to measure the antimalarial activity in plasma which results from artesunate and its principal metabolite, dihydroartemisinin. The oral study was repeated with 15 patients during convalescence. The mean absolute oral bioavailability of the antimalarial agent in patients with acute malaria was 61% (95% confidence interval [CI], 52 to 70%). The absorption and elimination of oral artesunate were rapid, with a mean elimination half-life of antimalarial activity of 43 min (95% CI, 33 to 53 min). Following oral administration to patients with acute falciparum malaria, peak antimalarial activity in plasma and the area under the plasma concentration-time curve were approximately double those during convalescence and the apparent volume of distribution and clearance were approximately half those during convalescence (P ≤ 0.005). Acute malaria is associated with a significant reduction in the clearance of artesunate- associated antimalarial activity.